AMI Asset Management Corporation »

Halozyme Therapeutics shares owned by AMI Asset Management Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by AMI Asset Management Corporation from 13F filings

Historical chart of AMI Asset Management Corporation investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by AMI Asset Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by AMI Asset Management Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.6M 137k 40.68
2023-12-31 $5.3M 143k 36.96
2023-09-30 $5.7M 148k 38.20
2023-06-30 $5.5M 152k 36.07
2023-03-31 $5.6M 146k 38.19
2022-12-31 $7.1M 126k 56.90
2022-09-30 $5.0M 126k 39.54
2022-06-30 $8.6M 195k 44.00
2022-03-31 $9.9M 249k 39.88
2021-12-31 $9.5M 236k 40.21
2021-09-30 $11M 259k 40.68
2021-06-30 $11M 250k 45.41
2021-03-31 $10M 247k 41.69
2020-12-31 $11M 246k 42.71
2020-09-30 $14M 518k 26.28
2020-06-30 $14M 526k 26.81